Nicole Loo
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatitis C virus research
- Liver Disease and Transplantation
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
Papers in
- Hepatology 10
- Hepatocellular Carcinoma Treatment and Prognosis 6
- Hepatitis C virus research 2
- Liver Disease and Transplantation 2
-
- Liver Disease Diagnosis and Treatment 5
- Hepatitis B Virus Studies 3
- Co-authors
- Samer Gawrieh (1 shared paper)Mazen Noureddin (1 shared paper)Naga Chalasani (1 shared paper)Eugene R. Schiff (1 shared paper)Kenneth J. Cusi (1 shared paper)Pankaj Patel (1 shared paper)Rizwana Mohseni (1 shared paper)Kris V. Kowdley (1 shared paper)
- Journals
- Clinical Gastroenterology and Hepatology (3 papers)Hepatology (2 papers)Applied and Environmental Microbiology (1 paper)Journal of Hepatology (1 paper)Mayo Clinic Proceedings (1 paper)
- Partner nations
- United StatesIndia
In The Last Decade
Nicole Loo
18 papers receiving 927 citations
Nicole Loo's Hit Papers
Peers
Comparison fields: 5 of 65
- Hepatology 200
- Epidemiology 557
- Bioengineering 6
- Cancer Research 27
- Biochemistry 11
Countries citing papers authored by Nicole Loo
This map shows the geographic impact of Nicole Loo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicole Loo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicole Loo more than expected).
Fields of papers citing papers by Nicole Loo
This network shows the impact of papers produced by Nicole Loo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicole Loo. The network helps show where Nicole Loo may publish in the future.
Co-authors
The 25 scholars most cited alongside Nicole Loo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Saroglitazar, a PPAR‐α/γ Agonist, for Treatment of NAFLD: A Randomized Controlled Double‐Blind Phase 2 Trial Hit paper breakdown → | 2021 | 311 |
| 2 | 2018 | 195 | |
| 3 | 2022 | 101 | |
| 4 | 2005 | 80 | |
| 5 | 2020 | 79 | |
| 6 | 2016 | 34 | |
| 7 | 2019 | 32 | |
| 8 | 2014 | 26 | |
| 9 | 2017 | 23 | |
| 10 | 2023 | 23 | |
| 11 | 2019 | 12 | |
| 12 | 2019 | 9 | |
| 13 | Exploring hepatitis B: a neglected disease. | 2012 | 8 |
| 14 | 2019 | 7 | |
| 15 | 2013 | 5 | |
| 16 | 2020 | 5 | |
| 17 | 2012 | 2 | |
| 18 | 2022 | 2 | |
| 19 | 2013 | 0 | |
| 20 | 2024 | 0 |
About Nicole Loo
Nicole Loo is a scholar working on Hepatology, Epidemiology, Biochemistry, Urology and Hematology, having authored 22 papers that have together received 954 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Liver Disease Diagnosis and Treatment (5 papers), Hepatitis B Virus Studies (3 papers), Blood transfusion and management (2 papers), Hepatitis C virus research (2 papers), Liver Disease and Transplantation (2 papers), Pediatric Hepatobiliary Diseases and Treatments (1 paper) and Platelet Disorders and Treatments (1 paper). The work is most often cited by research in Hepatology (200 citations), Epidemiology (557 citations), Bioengineering (6 citations), Cancer Research (27 citations) and Biochemistry (11 citations). Nicole Loo has collaborated with scholars based in United States and India. Frequent co-authors include Samer Gawrieh, Mazen Noureddin, Naga Chalasani, Eugene R. Schiff, Kenneth J. Cusi, Pankaj Patel, Rizwana Mohseni, Kris V. Kowdley, Michelle Lai and Chris R. Taitt. Their work appears in journals such as Clinical Gastroenterology and Hepatology, Hepatology, Applied and Environmental Microbiology, Journal of Hepatology and Mayo Clinic Proceedings.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.